 | • レポートコード：QYR9N7444 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、白血病がんのグローバル市場について調査・分析したレポートで、種類別（急性骨髄性白血病（AML）、慢性骨髄性白血病（CML）、急性リンパ芽球性白血病（ALL）、慢性リンパ性白血病（CLL））、用途別（化学療法、放射線療法、ターゲット療法、生物学的療法、幹細胞移植）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・白血病がんの世界市場規模 ・主要企業別市場シェア ・白血病がんの世界市場規模：種類別（急性骨髄性白血病（AML）、慢性骨髄性白血病（CML）、急性リンパ芽球性白血病（ALL）、慢性リンパ性白血病（CLL）） ・白血病がんの世界市場規模：用途別（化学療法、放射線療法、ターゲット療法、生物学的療法、幹細胞移植） ・白血病がんのアメリカ市場規模（種類別、用途別） ・白血病がんのヨーロッパ市場規模（種類別、用途別） ・白血病がんの中国市場規模（種類別、用途別） ・白血病がんの日本市場規模（種類別、用途別） ・白血病がんの東南アジア市場規模（種類別、用途別） ・白血病がんのインド市場規模（種類別、用途別） ・白血病がんの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・白血病がんの世界市場予測（2019年-2025年） ・白血病がんの地域別市場予測（2019年-2025年） ... |
Leukemia is a group ofcancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. High incidence rate of blood cancers and rise in incidence of leukaemia across the globe will drive the leukemia market.
In 2018, the global Leukemia Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Leukemia Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Leukemia Cancer development in United States, Europe and China.
The key players covered in this study
Biogen
GSK
Novartis
Pfizer
Roche
Takeda Oncology
Teva Pharmaceutical
Celgene
Daiichi Sankyo
EISAI
Sunesis Pharmaceuticals
Bristol-Myers Squibb
Spectrum Pharmaceuticals
Market segment by Type, the product can be split into
Acute Myeloid Leukaemia (AML)
Chronic Myeloid Leukaemia (CML)
Acute Lymphoblastic Leukaemia (ALL)
Chronic Lymphocytic Leukaemia (CLL)
Market segment by Application, split into
Chemotherapy
Radiation Therapy
Targeted Therapy
Biological Therapy
Stem Cell Transplant
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Leukemia Cancer status, future forecast, growth opportunity, key market and key players.
To present the Leukemia Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Leukemia Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Leukemia Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Acute Myeloid Leukaemia (AML)
1.4.3 Chronic Myeloid Leukaemia (CML)
1.4.4 Acute Lymphoblastic Leukaemia (ALL)
1.4.5 Chronic Lymphocytic Leukaemia (CLL)
1.5 Market by Application
1.5.1 Global Leukemia Cancer Market Share by Application (2014-2025)
1.5.2 Chemotherapy
1.5.3 Radiation Therapy
1.5.4 Targeted Therapy
1.5.5 Biological Therapy
1.5.6 Stem Cell Transplant
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Leukemia Cancer Market Size
2.2 Leukemia Cancer Growth Trends by Regions
2.2.1 Leukemia Cancer Market Size by Regions (2014-2025)
2.2.2 Leukemia Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Leukemia Cancer Market Size by Manufacturers
3.1.1 Global Leukemia Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Leukemia Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Leukemia Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Leukemia Cancer Key Players Head office and Area Served
3.3 Key Players Leukemia Cancer Product/Solution/Service
3.4 Date of Enter into Leukemia Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Leukemia Cancer Market Size by Type (2014-2019)
4.2 Global Leukemia Cancer Market Size by Application (2014-2019)
5 United States
5.1 United States Leukemia Cancer Market Size (2014-2019)
5.2 Leukemia Cancer Key Players in United States
5.3 United States Leukemia Cancer Market Size by Type
5.4 United States Leukemia Cancer Market Size by Application
6 Europe
6.1 Europe Leukemia Cancer Market Size (2014-2019)
6.2 Leukemia Cancer Key Players in Europe
6.3 Europe Leukemia Cancer Market Size by Type
6.4 Europe Leukemia Cancer Market Size by Application
7 China
7.1 China Leukemia Cancer Market Size (2014-2019)
7.2 Leukemia Cancer Key Players in China
7.3 China Leukemia Cancer Market Size by Type
7.4 China Leukemia Cancer Market Size by Application
8 Japan
8.1 Japan Leukemia Cancer Market Size (2014-2019)
8.2 Leukemia Cancer Key Players in Japan
8.3 Japan Leukemia Cancer Market Size by Type
8.4 Japan Leukemia Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Leukemia Cancer Market Size (2014-2019)
9.2 Leukemia Cancer Key Players in Southeast Asia
9.3 Southeast Asia Leukemia Cancer Market Size by Type
9.4 Southeast Asia Leukemia Cancer Market Size by Application
10 India
10.1 India Leukemia Cancer Market Size (2014-2019)
10.2 Leukemia Cancer Key Players in India
10.3 India Leukemia Cancer Market Size by Type
10.4 India Leukemia Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Leukemia Cancer Market Size (2014-2019)
11.2 Leukemia Cancer Key Players in Central & South America
11.3 Central & South America Leukemia Cancer Market Size by Type
11.4 Central & South America Leukemia Cancer Market Size by Application
12 International Players Profiles
12.1 Biogen
12.1.1 Biogen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Leukemia Cancer Introduction
12.1.4 Biogen Revenue in Leukemia Cancer Business (2014-2019)
12.1.5 Biogen Recent Development
12.2 GSK
12.2.1 GSK Company Details
12.2.2 Company Description and Business Overview
12.2.3 Leukemia Cancer Introduction
12.2.4 GSK Revenue in Leukemia Cancer Business (2014-2019)
12.2.5 GSK Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Leukemia Cancer Introduction
12.3.4 Novartis Revenue in Leukemia Cancer Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Leukemia Cancer Introduction
12.4.4 Pfizer Revenue in Leukemia Cancer Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Leukemia Cancer Introduction
12.5.4 Roche Revenue in Leukemia Cancer Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Takeda Oncology
12.6.1 Takeda Oncology Company Details
12.6.2 Company Description and Business Overview
12.6.3 Leukemia Cancer Introduction
12.6.4 Takeda Oncology Revenue in Leukemia Cancer Business (2014-2019)
12.6.5 Takeda Oncology Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Leukemia Cancer Introduction
12.7.4 Teva Pharmaceutical Revenue in Leukemia Cancer Business (2014-2019)
12.7.5 Teva Pharmaceutical Recent Development
12.8 Celgene
12.8.1 Celgene Company Details
12.8.2 Company Description and Business Overview
12.8.3 Leukemia Cancer Introduction
12.8.4 Celgene Revenue in Leukemia Cancer Business (2014-2019)
12.8.5 Celgene Recent Development
12.9 Daiichi Sankyo
12.9.1 Daiichi Sankyo Company Details
12.9.2 Company Description and Business Overview
12.9.3 Leukemia Cancer Introduction
12.9.4 Daiichi Sankyo Revenue in Leukemia Cancer Business (2014-2019)
12.9.5 Daiichi Sankyo Recent Development
12.10 EISAI
12.10.1 EISAI Company Details
12.10.2 Company Description and Business Overview
12.10.3 Leukemia Cancer Introduction
12.10.4 EISAI Revenue in Leukemia Cancer Business (2014-2019)
12.10.5 EISAI Recent Development
12.11 Sunesis Pharmaceuticals
12.12 Bristol-Myers Squibb
12.13 Spectrum Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Leukemia Cancer Key Market Segments
Table Key Players Leukemia Cancer Covered
Table Global Leukemia Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Leukemia Cancer Market Size Market Share by Type 2014-2025
Figure Acute Myeloid Leukaemia (AML) Figures
Table Key Players of Acute Myeloid Leukaemia (AML)
Figure Chronic Myeloid Leukaemia (CML) Figures
Table Key Players of Chronic Myeloid Leukaemia (CML)
Figure Acute Lymphoblastic Leukaemia (ALL) Figures
Table Key Players of Acute Lymphoblastic Leukaemia (ALL)
Figure Chronic Lymphocytic Leukaemia (CLL) Figures
Table Key Players of Chronic Lymphocytic Leukaemia (CLL)
Table Global Leukemia Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Chemotherapy Case Studies
Figure Radiation Therapy Case Studies
Figure Targeted Therapy Case Studies
Figure Biological Therapy Case Studies
Figure Stem Cell Transplant Case Studies
Figure Leukemia Cancer Report Years Considered
Table Global Leukemia Cancer Market Size 2014-2025 (Million US$)
Figure Global Leukemia Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Leukemia Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Leukemia Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Leukemia Cancer Market Share by Regions 2014-2019
Figure Global Leukemia Cancer Market Share by Regions 2014-2019
Figure Global Leukemia Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Leukemia Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Leukemia Cancer Market Share by Manufacturers (2014-2019)
Figure Global Leukemia Cancer Market Share by Manufacturers in 2018
Table Global Leukemia Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Leukemia Cancer Product/Solution/Service
Table Date of Enter into Leukemia Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Leukemia Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Leukemia Cancer Market Size Share by Type (2014-2019)
Figure Global Leukemia Cancer Market Size Market Share by Type (2014-2019)
Table Global Leukemia Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Leukemia Cancer Market Size Share by Application (2014-2019)
Figure Global Leukemia Cancer Market Size Market Share by Application (2014-2019)
Figure Global Leukemia Cancer Revenue Market Share by Application in 2018
Figure United States Leukemia Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Leukemia Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Leukemia Cancer Market Share (2018-2019)
Table United States Leukemia Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Leukemia Cancer Market Share by Type (2014-2019)
Table United States Leukemia Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Leukemia Cancer Market Share by Application (2014-2019)
Figure Europe Leukemia Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Leukemia Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Leukemia Cancer Market Share (2018-2019)
Table Europe Leukemia Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Leukemia Cancer Market Share by Type (2014-2019)
Table Europe Leukemia Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Leukemia Cancer Market Share by Application (2014-2019)
Figure China Leukemia Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Leukemia Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Leukemia Cancer Market Share (2018-2019)
Table China Leukemia Cancer Market Size by Type (2014-20189) (Million US$)
Table China Leukemia Cancer Market Share by Type (2014-2019)
Table China Leukemia Cancer Market Size by Application (2014-2019) (Million US$)
Table China Leukemia Cancer Market Share by Application (2014-2019)
Figure Japan Leukemia Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Leukemia Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Leukemia Cancer Market Share (2018-2019)
Table Japan Leukemia Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Leukemia Cancer Market Share by Type (2014-2019)
Table Japan Leukemia Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Leukemia Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Leukemia Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Leukemia Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Leukemia Cancer Market Share (2018-2019)
Table Southeast Asia Leukemia Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Leukemia Cancer Market Share by Type (2014-2019)
Table Southeast Asia Leukemia Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Leukemia Cancer Market Share by Application (2014-2019)
Figure India Leukemia Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Leukemia Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Leukemia Cancer Market Share (2018-2019)
Table India Leukemia Cancer Market Size by Type (2014-2019) (Million US$)
Table India Leukemia Cancer Market Share by Type (2014-2019)
Table India Leukemia Cancer Market Size by Application (2014-2019) (Million US$)
Table India Leukemia Cancer Market Share by Application (2014-2019)
Figure Central & South America Leukemia Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Leukemia Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Leukemia Cancer Market Share (2018-2019)
Table Central & South America Leukemia Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Leukemia Cancer Market Share by Type (2014-2019)
Table Central & South America Leukemia Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Leukemia Cancer Market Share by Application (2014-2019)
Table Biogen Company Details
Table Biogen Revenue in Leukemia Cancer Business (2014-2019) (Million US$)
Figure Biogen Revenue Growth Rate in Leukemia Cancer Business (2014-2019)
Table Biogen Recent Development
Table GSK Company Details
Table GSK Revenue in Leukemia Cancer Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Leukemia Cancer Business (2014-2019)
Table GSK Recent Development
Table Novartis Company Details
Table Novartis Revenue in Leukemia Cancer Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Leukemia Cancer Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Leukemia Cancer Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Leukemia Cancer Business (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in Leukemia Cancer Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Leukemia Cancer Business (2014-2019)
Table Roche Recent Development
Table Takeda Oncology Company Details
Table Takeda Oncology Revenue in Leukemia Cancer Business (2014-2019)(Million US$)
Figure Takeda Oncology Revenue Growth Rate in Leukemia Cancer Business (2014-2019)
Table Takeda Oncology Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Leukemia Cancer Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Leukemia Cancer Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Celgene Company Details
Table Celgene Revenue in Leukemia Cancer Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Leukemia Cancer Business (2014-2019)
Table Celgene Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Leukemia Cancer Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Leukemia Cancer Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table EISAI Company Details
Table EISAI Revenue in Leukemia Cancer Business (2014-2019)(Million US$)
Figure EISAI Revenue Growth Rate in Leukemia Cancer Business (2014-2019)
Table EISAI Recent Development
Table Sunesis Pharmaceuticals Company Details
Table Bristol-Myers Squibb Company Details
Table Spectrum Pharmaceuticals Company Details
Table Global Leukemia Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Leukemia Cancer Market Size Share by Regions (2019-2025)
Figure Global Leukemia Cancer Market Size Share by Regions in 2025
Figure United States Leukemia Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Leukemia Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Leukemia Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Leukemia Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Leukemia Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Leukemia Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Leukemia Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Leukemia Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Leukemia Cancer Market Size by Product (2019-2025)
Figure Global Leukemia Cancer Market Size by Product in 2025
Table Global Leukemia Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Leukemia Cancer Market Size by Application (2019-2025)
Figure Global Leukemia Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のT細胞性急性リンパ芽球性白血病の治療市場：市場規模・現状・予測 T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood cells called T lymphocytes.In 2018, the global T-cell Acute Lymphoblastic Leukemia Treatment market size was xx million US$ and it is expected to reach xx …- 世界の白血病治療市場：市場規模・現状・予測 Leukemia is a type of cancer which is formed in blood tissues. Leukemia occurs in bone marrow which is a soft tissue. Leukemia develops by the uncontrolled growth of blood cells in the bone marrow. Leukemia is also defined as a cancer of white blood cells. Leukemia therapeutics consists of three ste…
- 世界の白血病スクリーニング市場：市場規模・現状・予測 Currently, there are no standard leukemia screening methods recommended for regularly testing the leukemia affected patients. Specifically, no leukemia screening test has been reliably confirmed enough to detect the cancer in its early stages before the development of symptoms. Research and developm…
- 世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 世界のクリティカルケア製品市場：市場規模・現状・予測 Intensive care products or critical care products are the branch of medicine concerned with the diagnosis and management of life-threatening conditions requiring sophisticated organ support and invasive monitoring whereas chronic care products refers to medical care products which addresses pre-exis…